Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht 6200 MD, the Netherlands.
Department of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo, Brazil.
Neurobiol Learn Mem. 2019 Mar;159:6-15. doi: 10.1016/j.nlm.2019.02.003. Epub 2019 Feb 4.
Enhancement of synaptic plasticity through changes in neuronal gene expression is a prerequisite for improved cognitive performance. Moreover, several studies have shown that DNA methylation is able to affect the expression of (e.g. plasticity) genes that are important for several cognitive functions. In this study, the effect of the DNA methyltransferase (DNMT) inhibitor RG108 was assessed on object pattern separation (OPS) task in mice. In addition, its effect on the expression of target genes was monitored. Administration of RG108 before the test led to a short-lasting, dose-dependent increase in pattern separation memory that was not present anymore after 48 h. Furthermore, treatment with RG108 did not enhance long-term memory of the animals when tested after a 24 h inter-trial interval in the same task. At the transcriptomic level, acute treatment with RG108 was accompanied by increased expression of Bdnf1, while expression of Bdnf4, Bdnf9, Gria1 and Hdac2 was not altered within 1 h after treatment. Methylation analysis of 14 loci in the promoter region of Bdnf1 revealed a counterintuitive increase in the levels of DNA methylation at three CpG sites. Taken together, these results indicate that acute administration of RG108 has a short-lasting pro-cognitive effect on object pattern separation that could be explained by increased Bdnf1 expression. The observed increase in Bdnf1 methylation suggests a complex interplay between Bdnf methylation-demethylation that promotes Bdnf1 expression and associated cognitive performance. Considering that impaired pattern separation could constitute the underlying problem of a wide range of mental and cognitive disorders, pharmacological agents including DNA methylation inhibitors that improve pattern separation could be compelling targets for the treatment of these disorders. In that respect, future studies are needed in order to determine the effect of chronic administration of such agents.
通过改变神经元基因表达来增强突触可塑性是改善认知表现的前提。此外,多项研究表明,DNA 甲基化能够影响对几种认知功能很重要的(例如可塑性)基因的表达。在这项研究中,评估了 DNA 甲基转移酶(DNMT)抑制剂 RG108 对小鼠物体模式分离(OPS)任务的影响。此外,还监测了其对靶基因表达的影响。在测试前给予 RG108 给药会导致短暂的、剂量依赖性的模式分离记忆增强,但在 48 小时后不再存在。此外,当在同一任务中经过 24 小时的试验间隔后对动物进行测试时,RG108 的治疗并未增强动物的长期记忆。在转录组水平上,急性 RG108 处理伴随着 Bdnf1 表达的增加,而 Bdnf4、Bdnf9、Gria1 和 Hdac2 的表达在治疗后 1 小时内没有改变。在 Bdnf1 启动子区域的 14 个基因座的甲基化分析显示,在三个 CpG 位点上,DNA 甲基化水平呈反直觉增加。总的来说,这些结果表明,急性给予 RG108 对物体模式分离具有短暂的促认知作用,这可以用 Bdnf1 表达的增加来解释。观察到的 Bdnf1 甲基化增加表明 Bdnf 甲基化-去甲基化之间存在复杂的相互作用,这种相互作用促进了 Bdnf1 的表达和相关的认知表现。考虑到模式分离受损可能构成多种精神和认知障碍的潜在问题,包括改善模式分离的 DNA 甲基化抑制剂在内的药理学制剂可能是治疗这些疾病的有吸引力的靶点。在这方面,需要进行未来的研究,以确定此类药物的慢性给药的效果。